At a glance
ClinicalIndex Comparison RecordN/ACompleted· 90 enrolled
Drug / intervention
orthokeratology lensdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study to Evaluate Safety and Effectiveness of the Boston Orthokeratology (Oprifocon A) Shaping Lens in the Arise Orthokeratology Lens Design With Non-spherical Posterior Peripheral Curves
In Brief
A clinical study evaluating orthokeratology lens for Myopia. Completed, enrolled 90 participants across 6 sites.
Detailed Summary
The objective of this orthokeratology study is to evaluate the safety and effectiveness of the Arise Orthokeratology Lens with non-spherical posterior peripheral curves
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMyopia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartJul 2023
First PostedAug 2023
Primary CompletionJun 2024
TodayJul 2026
First PostedAug 9, 2023
Enrollment StartJul 11, 2023
Primary CompletionJun 27, 2024
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 2.9 years ago
Interventions
orthokeratology lensdevice
Each subject will wear the study lenses in both eyes overnight for approximately 3 months.